Serum LRG is a useful biomarker of endoscopic activity both in CD and UC during the adalimumab treatment.
No takes yet. Share an insight, caveat, or question.
Shinzaki et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: